Artemis Medicare Services Ltd Hits Intraday Low Amid Price Pressure

Intraday Performance and Price Movement

On 3 Feb 2026, Artemis Medicare Services Ltd recorded a significant intraday drop, with the stock price falling to Rs 220.55, marking a 7.87% decline from its previous close. The day’s overall price change stood at -7.39%, underperforming the hospital sector by 9.73%. This decline extended the stock’s consecutive losing streak to three sessions, during which it has shed 10.73% in value. The stock exhibited high intraday volatility of 6.19%, calculated from the weighted average price, indicating considerable price fluctuations throughout the trading day.

Technical indicators also reflected bearish trends, with Artemis Medicare trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling sustained downward momentum. This technical positioning suggests that the stock is currently facing resistance at multiple levels, limiting any immediate recovery attempts.

Market Context and Broader Indices

The broader market environment on the same day was characterised by a loss of momentum in the Sensex after a strong gap-up opening. The index initially surged by 3,656.74 points but subsequently retreated by 1,344.40 points, closing at 83,978.80, down 2.83%. Despite this pullback, the Sensex remained close to its 52-week high of 86,159.02, just 2.6% away. The index was trading below its 50-day moving average, although the 50DMA itself was positioned above the 200DMA, indicating a mixed technical outlook for the broader market.

Market leadership was concentrated among mega-cap stocks, which helped limit the overall market decline. However, Artemis Medicare, a mid-cap hospital sector stock, did not benefit from this trend and instead lagged significantly behind the Sensex’s 2.79% gain on the day.

Relative Performance Over Multiple Timeframes

Artemis Medicare’s recent performance contrasts sharply with the broader market’s trajectory. Over the past week, the stock declined by 4.23%, while the Sensex gained 2.55%. The one-month performance shows a more pronounced divergence, with Artemis Medicare falling 20.03% against the Sensex’s modest 2.11% decline. Over three months, the stock dropped 8.94%, compared to the Sensex’s near-flat performance (-0.04%).

Longer-term figures reveal a challenging period for Artemis Medicare. The stock has lost 29.41% over the past year, whereas the Sensex has appreciated by 8.76%. Year-to-date, Artemis Medicare is down 17.69%, significantly underperforming the Sensex’s 1.49% decline. Despite these recent setbacks, the stock’s three- and five-year returns remain robust at 236.68% and 972.61% respectively, well above the Sensex’s corresponding gains of 37.98% and 67.04%. This indicates that while the stock has faced short-term pressures, its longer-term growth trajectory has been strong.

Mojo Score and Rating Update

Artemis Medicare Services Ltd currently holds a Mojo Score of 54.0, categorised as a Hold. This represents a downgrade from its previous Buy rating, which was revised on 1 Feb 2026. The Market Cap Grade stands at 3, reflecting a mid-tier market capitalisation relative to peers. The rating adjustment aligns with the recent price weakness and technical underperformance, signalling a more cautious stance on the stock’s near-term outlook.

Sector and Industry Considerations

Operating within the hospital sector, Artemis Medicare’s performance today diverged from the broader healthcare space, which has seen mixed results amid ongoing market volatility. The hospital industry is sensitive to various macroeconomic factors, including regulatory changes, patient volumes, and cost pressures. While the sector has shown resilience in recent years, individual stocks like Artemis Medicare are currently experiencing headwinds that have contributed to the price pressure observed today.

Volatility and Trading Dynamics

The heightened intraday volatility of 6.19% underscores the unsettled trading conditions for Artemis Medicare. Such volatility often reflects uncertainty among market participants and can be driven by a combination of profit-taking, technical selling, and broader market sentiment shifts. The stock’s failure to hold above key moving averages further exacerbates selling pressure, as technical traders may view these levels as resistance points.

Despite the broader market’s partial recovery from early losses, Artemis Medicare’s price action remained subdued, indicating that immediate pressures are outweighing any positive sentiment. The stock’s underperformance relative to the Sensex and its sector peers highlights the challenges it faces in regaining momentum in the near term.

Summary of Key Metrics

To summarise, Artemis Medicare Services Ltd’s key performance indicators for 3 Feb 2026 are as follows:

• Intraday low: Rs 220.55 (-7.87%)
• Day change: -7.39%
• Underperformance vs sector: -9.73%
• Consecutive days of decline: 3
• Three-day return: -10.73%
• Intraday volatility: 6.19%
• Mojo Score: 54.0 (Hold, downgraded from Buy on 1 Feb 2026)
• Market Cap Grade: 3

These figures collectively illustrate the stock’s current challenges amid a market environment that remains volatile and uncertain.

Conclusion

Artemis Medicare Services Ltd’s decline to its intraday low of Rs 220.55 on 3 Feb 2026 reflects a combination of technical weakness, sector-specific pressures, and broader market dynamics. The stock’s underperformance relative to the Sensex and hospital sector, coupled with its trading below all major moving averages, signals continued price pressure in the immediate term. Elevated volatility and a recent downgrade in rating further contribute to a cautious outlook on the stock’s near-term price action.

Investors and market participants will likely monitor Artemis Medicare’s price behaviour closely in the coming sessions to assess whether it can stabilise or if the downward trend will persist amid ongoing market fluctuations.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →